| Plethico Pharmaceuticals has reported a consolidated total income from operations of Rs 111.45 crore and a net loss of Rs 4.07 crore for the quarter ended Dec '14. | | For the quarter ended Dec 2013 the consolidated total income from operations was Rs 364.38 crore and net profit was Rs 44.07 crore. | | Plethico Pharma shares closed at 37.60 on February 13, 2015 (NSE) and has given -15.32% returns over the last 6 months and -8.85% over the last 12 months. |
|
| | Plethico Pharmaceuticals | | Consolidated Quarterly Results | -------- in Rs. Cr. -------- |
|
| Dec '14 | Sep '14 | | | Dec '13 | | Net Sales/Income from operations | 108.20 | 260.50 | | | 364.04 | | Other Operating Income | 3.25 | 2.46 | | | 0.34 | | Total Income From Operations | 111.45 | 262.96 | | | 364.38 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 5.23 | 63.29 | | | 17.06 | | Purchase of Traded Goods | 49.89 | 69.61 | | | 152.66 | | Increase/Decrease in Stocks | 7.44 | 6.95 | | | 24.51 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 9.35 | 30.43 | | | 45.16 | | Depreciation | 10.82 | 15.42 | | | 27.42 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 21.20 | 41.04 | | | 25.26 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 7.51 | 36.23 | | | 72.31 | | Other Income | 0.13 | 0.43 | | | -0.04 | | P/L Before Int., Excpt. Items & Tax | 7.64 | 36.66 | | | 72.26 | | Interest | 11.70 | 51.99 | | | 28.94 | | P/L Before Exceptional Items & Tax | -4.07 | -15.33 | | | 43.32 | | Exceptional Items | -- | -- | | | -- | | P/L Before Tax | -4.07 | -15.33 | | | 43.32 | | Tax | -- | -9.02 | | | -0.75 | | P/L After Tax from Ordinary Activities | -4.07 | -6.31 | | | 44.07 | | Prior Year Adjustments | -- | -- | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | -4.07 | -6.31 | | | 44.07 | | Minority Interest | -- | -- | | | -- | | Share Of P/L Of Associates | -- | -- | | | -- | | Net P/L After M.I & Associates | -4.07 | -6.31 | | | 44.07 | | Equity Share Capital | 34.07 | 34.07 | | | 34.07 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | -1.19 | -1.85 | | | 12.94 | | Diluted EPS | -1.19 | -1.85 | | | 12.94 | | EPS After Extra Ordinary | | | | | | | Basic EPS | -1.19 | -1.85 | | | 12.94 | | Diluted EPS | -1.19 | -1.85 | | | 12.94 | | Public Share Holding | | | | | | | No Of Shares (Crores) | 0.96 | 0.97 | | | 0.79 | | Share Holding (%) | 28.31 | 28.33 | | | 23.06 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | 2.09 | 2.09 | | | 2.27 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 85.74 | 85.75 | | | 86.73 | | - Per. of shares (as a % of the total Share Cap. of the company) | 61.46 | 61.46 | | | 66.73 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | 0.35 | 0.35 | | | 0.35 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 14.26 | 14.25 | | | 13.27 | | - Per. of shares (as a % of the total Share Cap. of the company) | 10.22 | 10.21 | | | 10.21 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
